Non–Small Cell Lung Cancer Coverage from Every Angle

Pranshu Mohindra, MD, MBBS, on Considering Intensity-Modulated Proton Therapy–Based Reirradiation for Patients With NSCLC

Posted: Wednesday, February 2, 2022

Pranshu Mohindra, MD, MBBS, of the University of Maryland School of Medicine and the Maryland Proton Treatment Center, discusses his findings on the benefits of intensity-modulated proton therapy–based reirradiation for patients with non–small cell lung cancer and the feasibility of offering this treatment to all patients with this type of lung cancer.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.